EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia

Xiaohong Sun iD, Wei Liu, Binyu Luo, Dongwei Ma, Hindu Kalluru, Yangmei Zhou, Jin Li, Ao Peng, Yuwang Liu, Xin Tong, Lei Sun, John Teeter und 2 weitere

Haemophilia · 2023

DOI: 10.1111/hae.14814 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Haemophilia, 2023. Verfasst von Xiaohong Sun und 13 weiteren Autor:innen. Beteiligte Einrichtung: Development China, Pfizer Investment Co. Ltd., Beijing, China. Hauptthemen laut MEDLINE: Hemophilia A. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemophilia AHumansEast Asian PeopleAntibodies, Monoclonal, HumanizedDose-Response Relationship, DrugDouble-Blind MethodHealthy Volunteers

Substanzen

marstacimabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Development China, Pfizer Investment Co. Ltd., Beijing, China.
  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Pfizer (China) R&D Center, Shanghai, China.
  • Pfizer Healthcare India Private Ltd., Chennai, India.
  • Pfizer Inc, Groton, Connecticut, USA.
  • Pfizer Inc, Collegeville, Pennsylvania, USA.

ORCID-Profile: Xiaohong Sun, Renchi Yang

Förderung

  • Pfizer

Zitieren

APA

Sun, X., Liu, W., Luo, B., Ma, D., Kalluru, H., Zhou, Y., Li, J., Peng, A., Liu, Y., Tong, X., Sun, L., Teeter, J., Raje, S., & Yang, R. (2023). Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia. Haemophilia. https://doi.org/10.1111/hae.14814

Vancouver

Sun X, Liu W, Luo B, Ma D, Kalluru H, Zhou Y, et al. Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia. Haemophilia. 2023. doi:10.1111/hae.14814

BibTeX
@article{Sun2023,
  author = {Sun, Xiaohong and Liu, Wei and Luo, Binyu and Ma, Dongwei and Kalluru, Hindu and Zhou, Yangmei and Li, Jin and Peng, Ao and Liu, Yuwang and Tong, Xin and Sun, Lei and Teeter, John and Raje, Sangeeta and Yang, Renchi},
  title = {Safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of marstacimab in Chinese participants with severe haemophilia},
  journal = {Haemophilia},
  year = {2023},
  doi = {10.1111/hae.14814}
}
Kostenlos starten →